Skip to content
ETEN
Findshops
Science & Health

Boots Launches Medical Cannabis Prescription Service in the UK

Illustratiivne lai kujutis Bootsi apteegist Suurbritannias ja meditsiinitöötajast

Boots, one of the United Kingdom’s best-known pharmacy chains, has launched a private medical cannabis prescribing service. Announced on 16 November 2026, SureLeaf allows certain patients with long-term health conditions to undergo an online specialist assessment and, if clinically appropriate, receive a prescription for medical cannabis. This does not mean cannabis has become available over the counter in British pharmacies.

What exactly is Boots offering?

The service operates through Boots Online Doctor, the company’s digital healthcare platform. SureLeaf is a paid private healthcare service built around specialist medical assessment and ongoing monitoring. A prescription is not guaranteed: patients must first be assessed for eligibility.

According to Boots, the service is intended for patients aged 25 or over who have an eligible condition and whose symptoms have not been adequately relieved by conventional treatments.

Which conditions may qualify for an assessment?

The service lists certain chronic pain conditions, including neuropathic pain, fibromyalgia, chronic back or neck pain, and osteoarthritis. Generalised anxiety disorder and insomnia are also among the conditions considered. This list does not mean medical cannabis is proven effective for every condition, or that everyone with a listed diagnosis will receive a prescription.

Boots presents medical cannabis as a possible additional option where existing treatments have not sufficiently improved a patient’s symptoms.

Several checks are required before a prescription

The process starts with an online eligibility assessment. Patients who may qualify are offered a video consultation with a relevant consultant listed on the UK’s specialist medical register. A proposed treatment plan is then reviewed by a multidisciplinary team, including a second independent specialist.

After treatment begins, SureLeaf says the first follow-up will take place after 28 days, with further reviews at least every three months. Assessments may consider pain, sleep, mood and quality of life.

Why is the involvement of a major pharmacy chain significant?

Specialist prescriptions for medical cannabis have been possible in the UK under certain conditions since 2018. Until now, the sector has largely been associated with specialist private clinics. A well-known pharmacy brand such as Boots entering the market may make the service more visible and bring it into wider healthcare discussions.

The Pharmaceutical Journal reported an assessment by Mike Barnes, founder of a medical cannabis clinicians’ association, that involvement from such a major company could lend the sector greater credibility. That is an expert opinion, not evidence of clinical effectiveness.

Is the effectiveness of medical cannabis scientifically established?

The launch does not establish that medical cannabis is effective for all the conditions listed. The Pharmaceutical Journal drew attention to scientific reviews published in 2026 that did not find clear evidence of effectiveness for cannabis-based medicines in chronic pain, or a statistically significant treatment effect for anxiety. This is one reason why individual clinical assessment and follow-up matter.

Boots also said it was discussing a potential research collaboration with the University of Nottingham to study patients’ experiences and outcomes. The collaboration is being considered; it is not a completed study.

What does this mean for Estonia?

Boots’ new UK service does not change Estonia’s medical cannabis regulations or automatically improve access in Estonia. It does, however, illustrate that Europe’s medical cannabis sector now includes major established healthcare businesses, not only smaller specialist clinics.

For more context, see our guides to cannabis laws in Estonia and the effects and risks of cannabis.

Sources

Share article
REKLAAMIPIND
Your ad here

Advertising space available.

Get in touch ↗

Lisa kommentaar

Your email address will not be published. Required fields are marked *